BIOMAT Database Logo BIOMAT Database Logo

Immune checkpoint inhibitor-induced myo-fasciitis. 2017

Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Division of Rheumatology, Department of Internal Medicine.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009220 Myositis Inflammation of a muscle or muscle tissue. Inflammatory Myopathy,Myositis, Focal,Myositis, Infectious,Idiopathic Inflammatory Myopathies,Idiopathic Inflammatory Myopathy,Idiopathic Inflammatory Myositis,Infectious Myositis,Inflammatory Muscle Diseases,Inflammatory Myopathies, Idiopathic,Inflammatory Myopathy, Idiopathic,Muscle Diseases, Inflammatory,Myopathies, Idiopathic Inflammatory,Myopathy, Inflammatory,Myositis, Proliferative,Focal Myositides,Focal Myositis,Infectious Myositides,Inflammatory Muscle Disease,Inflammatory Myopathies,Muscle Disease, Inflammatory,Myopathies, Inflammatory,Myopathy, Idiopathic Inflammatory,Myositides,Myositides, Focal,Myositides, Infectious,Myositides, Proliferative,Proliferative Myositides,Proliferative Myositis
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005208 Fasciitis Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis (FASCIITIS, NECROTIZING), a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma. Fascitis,Fasciitides,Fascitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077594 Nivolumab A genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA. BMS-936558,MDX-1106,ONO-4538,Opdivo,BMS 936558,BMS936558,MDX 1106,MDX1106,ONO 4538,ONO4538
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune checkpoint inhibitor-induced lymphocytic fasciitis.
December 2018, Internal medicine journal,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
[Immune checkpoint inhibitor-induced eosinophilic fasciitis: a case report and literature review].
February 2023, Zhonghua nei ke za zhi,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune Checkpoint Inhibitor-induced Enterocolitis.
July 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune Checkpoint Inhibitor-Induced Uveitis.
August 2020, Ocular immunology and inflammation,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune checkpoint inhibitor-induced hypophysitis.
November 2021, Diagnostic and interventional imaging,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune Checkpoint Inhibitor-induced Myositis.
May 2024, Rheumatic diseases clinics of North America,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune checkpoint inhibitor-induced myopericarditis.
March 2024, BMJ case reports,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
[IMMUNE CHECKPOINT INHIBITOR-INDUCED DIABETES MELLITUS].
October 2021, Harefuah,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune checkpoint inhibitor-induced musculoskeletal manifestations.
January 2021, Rheumatology international,
Dimitrios Daoussis, and Pantelis Kraniotis, and Stamatis-Nick Liossis, and Aikaterini Solomou
Immune Checkpoint Inhibitor-induced Fanconi Syndrome.
April 2020, Cureus,
Copied contents to your clipboard!